xCures helps patients and their doctors beat late stage and/or recalcitrant cancers. We operate an AI-assisted platform that provides highly-tailored, up-to-date information regarding the optimal (investigational or approved) therapies to consider in specific patient cases. In doing so, xCures’ platform prospectively generates real-world evidence for clinical studies and decentralized trials. xCures is founded by serial entrepreneurs and led by a management team with more than 10 successful combined exits under their belts. We are backed by Vanedge Capital Partners in a large seed round, are already bringing in meaningful revenue, and are raising a Series A to scale growth.